StockWatch
·

MARKSANS PHARMA LTD. Q4 FY25 Results

MARKSANSQ4 FY25 Results
Filing
MetricValue (₹ Cr)vs Q3 FY25
Revenue70.8589.6%
Total Income72.5089.8%
Expenditure60.8989.3%
PBT11.6191.9%
Net Profit9.0791.4%
OPM17.75%4.25pp
NPM12.51%2.29pp
EPS2.0013.4%
View full financials

Informational and educational content only. Not investment advice.